Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control® platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the system.
Open Positions
Director, DMPK
PhD or equivalent in relevant field, 7+ years of experience in pharmaceutical/biotechnology setting, strong understanding of DMPK principles and ADME/PK assays in drug development
Principal Research Associate, Mass Spectrometry
Bachelor's or Master's degree in relevant field, 3+ years of experience in mass spectrometry, and strong interest in instrument operation, maintenance, and troubleshooting